GLP-1 drugs like Ozempic, Trulicity and Victoza were associated with a slightly lower likelihood of developing epilepsy in a large group of people with type 2 diabetes. GLP-1 drugs may be connected to a lower chance of developing epilepsy in people with type 2 diabetes, offering an intriguing early signal for researchers. Participants who used … Continue reading Ozempic Shows a Possible Hidden Effect on Epilepsy Risk